EbeneMagazine – United States – Align’s ClinCheck Suite (ALGN) now commercially available


Align Technology, Inc. ALGN recently announced the commercial availability of its proprietary treatment planning software ClinCheck. The software was notably scheduled to be showcased at the Align Asia Pacific Virtual Symposium (« APAC ») on October 16

For investors, ClinCheck software provides physicians with a 3D model of planned tooth movements throughout Invisalign treatment The software includes the ClinCheck Pro 60 and the ClinCheck “In-Face” visualization tool

Notably, the ClinCheck « In-Face » visualization tool is an enhanced digital clinical tool for the physician that combines a photo of the patient’s face with their 3D Invisalign treatment plan, creating a personalized view of appearance. of her new smile

With the latest commercial availability announcement, Align Technology aims to strengthen its position in the global transparent aligner market

The Invisalign system is the company’s proprietary method of treating malocclusion (imperfect positioning of teeth when jaws are closed) This is based on a proprietary computer simulated virtual treatment plan and a series of removable plastic aligners clear doctor prescribed, custom made and clear

Once digital patient information and data is obtained, Align Technology generates a personalized 3D treatment plan proposal, known as the ClinCheck treatment plan, using the company’s proprietary software The Plan A patient’s ClinCheck treatment plan simulates expected dental movements in stages and details the timing and location of any item or accessory to be used during treatment

Availability of ClinCheck Pro 60 ensures transfer of digital Invisalign treatment plans to the cloud, making ClinCheck treatment planning tools and features available to physicians at their convenience Cloud-based solution enables physicians access treatment plans on all devices and ensure availability of the latest software version without the need for additional downloads Additionally, it provides users with a treatment planning solution that provides physicians with a more intuitive design and improved user experience.

The ClinCheck In-Face Visualization Tool is designed to assist physicians in their digital treatment planning and to increase patients’ understanding of the benefits provided by Invisalign therapy through enhanced visualizations of their patient outcomes. Personalized treatment Notably, the workflow combines three components of Align Technology’s digital treatment platform: Invisalign Photo Uploader for patient photos, iTero intraoral scanner to capture the data needed for the 3D model of the patient’s dentition and ClinCheck Pro 60

According to a report by Verified Market Research, the global transparent aligners market was valued at $ 1.89 billion in 2019 and is expected to reach $ 881 billion by 2027 at a CAGR of around 211% Factors such as growing awareness people to dental care, increasing customer spending and technological advancements are likely to drive the market

Given the market potential, the latest commercial availability is expected to significantly boost Align Technology’s business

The company announced in September the addition of the Steraligner aligner cleaning system to the Invisalign Doctor Site and InvisalignAccessoriescom In the same month, Align Technology launched the Invisalign Stickables, which are sticker accessories designed exclusively for use with SmartTrack material in Invisalign Clear Aligners

In August, the company took another step forward by treating the millionth patient from Tokyo, Japan in the APAC region with its Invisalign system According to the company’s estimates, the Invisalign system is the only clear aligner with one million patients in the APAC region and more than eight million patients worldwide

The same month, the company signed an agreement with the National Football League (« NFL ») to make the Invisalign brand the official Clear Aligner sponsor of the NFL. In addition, the same month, Align Technology signed an agreement a multi-year partnership with the New Orleans Saints, making the Invisalign brand the “Official Smile” partner of the Saints

The company’s shares gained 567% last year against the industry’s 10% growth and the S&P 500 composite 152% increase

Some higher ranked stocks from the wider medical space are QIAGEN NV QGEN, Thermo Fisher Scientific Inc TMO and Boston Scientific Corporation BSX

QIAGEN’s long-term profit growth rate is estimated at 172% It currently boasts a Zacks # 1 rank (strong buy) You can see the full list of stocks in the current Zacks # 1 rank here

Thermo Fisher’s long-term profit growth rate is estimated at 155% It currently sports a Zacks # 1 rank

Boston Scientific’s long-term profit growth rate is estimated at 10% The company currently holds a Zacks # 2 (Buy) rank

Each has been hand-picked by a Zacks expert as the # 1 preferred title to earn 100% or more in 2020 Each comes from a different industry and has unique qualities and catalysts that could fuel exceptional growth

Most of the stock in this report is flying under the radar on Wall Street, which provides a great opportunity to get into the ground floor

Want the latest recommendations from Zacks Investment Research? Today you can download 7 Best Stocks for the Next 30 Days Click to Get This Free Report QIAGEN NV (QGEN): Free Stock Analysis Report Boston Scientific Corporation (BSX): Free Stock Analysis Report Align Technology , Inc (ALGN): Free Stock Analysis Report Thermo Fisher Scientific Inc (TMO): Free Stock Analysis Report To read this article on Zackscom click here

Tesla’s latest quarterly figures beat analysts’ expectations for revenue and earnings per share, bringing in $ 877 billion in third-quarter revenue With the report that Tesla had already beaten Wall Street’s expectations for deliveries earlier this month, the question for today’s earnings call was how efficient (and, by extension, profit) the electric car and battery business was able to eliminate from its manufacturing processes Now we have the answer, as Tesla reported profits of $ 809 million on revenue of $ 8 and $ 77 billion for the third quarter

Jim Cramer discussed on CNBC’s « Mad Money » Tuesday about his « basket of winners » if former Vice President Joe Biden wins the presidential election Cramer believes that if Biden wins the election, Democrats will be eager to spend money in the solar industry Two solar stocks he loves: First Solar, Inc (NASDAQ: FSLR) and Tesla, Inc (NASDAQ: TSLA) Infrastructure is another industry Cramer thinks it will win if Biden wins If there’s a Democratic sweep, we might see an infrastructure package Cramer likes these two infrastructure stocks: Caterpillar Inc (NYSE: CAT) and Deere & Company (NYSE: DE) See also: Trump and Biden will mute the microphones in the final debate when Rival delivers an opening speech Cramer says the main difference between President Donald Trump and Biden is trade He believes if Biden wins there will be no more trade war with China Cramer loves these a Chinese ctions: 3M Company (NYSE: MMM), Emerson Electric Co (NYSE: EMR) and Otis Worldwide Corporation (NYSE: OTIS) The biggest winners are Chinese consumer games, which are Starbucks Corporation (NASDAQ: SBUX), Apple Inc (NASDAQ: AAPL) and Nike, Inc (NYSE: NKE) according to Cramer He believes Nike will hit the $ 135 price bracket due to the company’s Chinese operations See more from Benzinga * Option trades for this crazy market: Get Benzinga Options to Track High Conviction Business Ideas * Container Stores Soar On Second Quarter Sales, Marie Kondo Partnership * Jason Snipe Gives Bullish Thoughts On Wayfair, AutoZone (C) 2020 Benzingacom Benzinga Does Not Provide no investment advice All rights reserved

Markets have shown two themes in recent weeks, a combination of uncertainty and uptrend Day to day it is impossible to predict what will happen, but the larger scale movement is at the Going forward, all we know is that current events will increase uncertainty The earnings season has begun As publicly traded companies release their third quarter results, we’ll get an idea more clear about the nature of the economic recovery The first quarter was a disaster, the second quarter was better than expected; while Q3 is also expected to beat expectations, no one will be surprised if the stomach collapses So far our first clue was the September jobs report, which was below expectations, but nonetheless showed some 661,000 new jobs last monthThe big wild card, of course, is the national elections, in a few weeks President Trump is fighting for his political life and the Democratic opposition is fighting to regain control of the levers of government It is an environment which practically encourages investors to take protective measures for their portfolios And it is possible; even in an uncertain time, there are dividend stocks that promise reliable returns and risk mitigation.Using the TipRanks database, we mined two stocks with strong buy ratings and dividend yields high Wall Street analyst body sees them as ripe for return on investment, while dividend yield of 9% or more promises relief from current low rate regime Hoegh LNG Partners (HMLP) Hoegh operates floating gas services , including storage facilities and regasification units that can serve as LNG import terminals in the absence of onshore infrastructure At the end of last summer, Hoegh announced a new CEO, as part of the ‘a normal leadership transition in the business The remarkable aspect was that the transition occurred during the COVID outbreak – and the company posted positive revenues and profits during this time, avoiding the heavy losses that have hit some of its competitors Hoegh’s EPS has fluctuated quarter-to-quarter over the past two years, but Q2 numbers were in line with the long-term average, and the outlook for Q3, to be released next month, is in the same forkStable earnings generally mean a stable dividend, and HMLP delivers The company has a 6-year history of dividend reliability, and the payout, of 44 cents per common share, has remained stable through 2020 The $ 1 76 annualized payouts yield a Impressive 155% yield That’s more than 7 times the average listed dividends S&PLiam Burke, of B Riley FBR, considers himself a fan He writes: “Despite the short-term decline in global LNG consumption caused by the coronavirus , there is a strong underlying demand for LNG, which is expected to grow by over 3% to 5% per year through 2030, paving the way for continued demand for High Efficiency Floating Storage and Regasification Units (FSRUs) beyond current contractual periods We continue to believe in the long term strength of the LNG market and the underlying HMLP charters despite counterparty risks short-term drop in LNG consumption linked to COVID-19 « Burke rates HMLP stocks at a buy, and his price target of $ 17 indicates confidence in a 45% upside potential (To watch Burke’s track record, click here) Overall, Wall Street recently awarded 3 buys and 1 HMLP hold, for a Strong Buy consensus rating The average price target is $ 1367, suggesting a 19% rise by compared to the current trading level of $ 11.41 (See HMLP market analysis on TipRanks) Hess Midstream Operations (HESM) Next on today’s dividend champion list is industry player Hess Midstream American oil and gas groin Hess provides infrastructure services for the collection, processing, storage and transportation of crude oil and natural gas products in the Bakken Formation of North Dakota Production companies have kept the product in circulation despite the coronavirus, which is one of the reasons for the low prices in the oil markets – but it has also maintained the demand from middlemen Hess benefited from the continued need for his technical knowledge of the pipeline system, and the result was that, while much of the oil industry had to retreat recently, Hess experienced only modest revenue losses, while profits remained in line with their recent 2- year history Second quarter EPS was 29 cents; lower than Q1, but higher than 4Q19Hess put its regular profits to the advantage of shareholders, with a dividend that has been increased quarterly for the past 2 years The last payment, sent in August, was 44 cents per common share This yielded a 986% return, strong by all standards. JPMorgan analyst Tarek Hamid says of Hess: “The unique pricing model that underpins core profitability remains unmatched and further helps eliminate (to some extent) DAPL’s uncertainty compared to its peers Longer-term growth prospects could come in the form of asset-level acquisitions and potentially a framework linked to Hess’s GOM position, but management has taken a conservative approach to the company. M&A HESM will burn cash this year, although our modeling indicates a turnaround in FCF generation in FY21 on lower capital intensity and higher y / y profitability. ”To this end, JPMorgan gives HESM an overweight rating (ie Buy) with a price target of $ 23 This figure suggests a 40% rise in HESM stocks in the coming months Overall, the Strong Buy consensus rating of this stock is supported by 4 buys and 1 hold. sell $ 16.46, and the average price target of $ 19.75 indicates upside potential of 20% (See HESM Market Analysis on TipRanks) For great ideas for trading dividend stocks at attractive valuations, visit the best stocks to buy from TipRanks, a newly launched tool that brings together all information about the TipRanks stocks Disclaimer: The opinions expressed in this article are solely those of the featured analysts The c ontenu is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment

There-is-no-alternative, or TINA, has been a pretty solid investment strategy for those riding the stock market wave But for Deutsche Bank’s international private bank chief investment office, it has its limits

Coronavirus mRNA vaccine in development by Pfizer Inc (NYSE: PFE) and BioNTech SE – ADR (NASDAQ: BNTX) is set to apply for emergency use authorization, according to SVB Leerink Pfizer analyst: Geoffrey Porges has a Market Perform rating on Pfizer stock Pfizer’s thesis: Pfizer-BioNTech’s BNT162b2 vaccine candidate will likely report interim efficacy results in the coming weeks, then move on to a dossier of emergency use, Porges said in a noteBNT162b2 has a high likelihood of meeting its efficacy and safety results and at least moving to initial emergency approval in November, analyst said“We believe there is a high likelihood BNT162b2 will obtain EUA for high-risk populations in Q4” Related Link: The Week Ahead in Biotech: FDA Decision on Spectrum Pharma, Biogen and Abbott Revenue , cancer conference SVB Leerink’s vaccine market model assumes an ongoing risk of SARS-CoV-2, requiring revaccination every two years to maintain protective immunity, Porges told me Relatively high vaccine penetration , in the order of 80%, is likely in healthcare workers and high-risk adults such as the elderly and people with co-morbidities, and low penetration is expected for low-risk adults and ultimately children, analyst said »We also expect a first large vaccination bolus in 2021-2022E given the size of the COVID-naive population, followed by a stable trend of revaccination until 2030E, » he said. Porges plans two initial doses for the initiation vaccination, followed by a single booster every two years Given Pfizer’s leadership position in clinical development, strong immunogenicity data and a seemingly clean safety profile, BNT162b2 is expected to take over 50% of the market share initially, which would decrease over time to 25% as more products enter the market, the analyst told me The price of the Pfizer’s vaccine was $ 30 per dose in the US and $ 23 in areas outside of the US initially, with the price falling to $ 11- $ 15 per dose over time, he said. said By integrating BNT162b2 into SVB Leerink’s Pfizer model with an 80% probability of success, Porges said it expects it to generate $ 3.54 billion in revenue in 2021 and $ 1.57 billion in 2024 PFE price share: Pfizer shares fell 056% to $ 37 28 at last check Wednesday Related link: FDA COVID-19 Vaccine Guidelines Show «  Substantial  » Developer Obligations: Latest Analyst Notes for PFE DateFirmActionOctober 2020Atlantic EquitiesDowngradesOverweightNeutral Sep 2020Berenberg initiates coverage onHold July 2020Morgan StanleyMaintainsEgal-Weight Options trades for this crazy market : Get Benzinga Options to Track High Conviction Business Ideas * The Daily Biotech Pulse: Prothena Progress in Parkinson’s Disease Pipeline, Fast Track for Xeris, Biogen Earnings * Moderna nears finish line for study enrollment 2020 phase 3 coronavirus (C) vaccine Benzingacom Benzinga does not provide investment advice All rights reserved

Bayer Monsanto’s division on Wednesday lost a final call in a long-standing legal battle in France in which the agricultural chemicals maker was held responsible for the accidental inhalation of a weedkiller by a farmer Monsanto had tried to overturn a decision of an appeals court in 2019 which found that information on the safety of the company’s products was insufficient in relation to the accident involving farmer Paul François in 2004 France’s highest court dismissed Monsanto’s latest appeal in a decision released Wednesday, paving the way for another court to decide on damages to be awarded to François

Biden proposed to raise capital gains tax rate from 20% to 396% for those earning more than $ 1 million Biden should win the presidency and his Democratic Party should take control Senate and keep control of the House of Representatives in November 3 election to make his tax proposals law The Biden campaign did not immediately respond to a request for comment

(Bloomberg) – Traders may want to consider purchasing insurance, just in case the polls are wrong again Global financial markets are increasingly holding the view that Democratic challenger Joe Biden won’t just overthrow President Donald Trump at next month’s U election, but that he will also have a friendly Congress US stocks and Treasury yields have risen in the prospect that a Biden administration will usher in a bigger fiscal stimulus, while the dollar fell and implied market turbulence measures – aided in part by support from the US central bank – have been moderate Yet as national opinion polls and in rotating critical states have Biden in mind, the memory of the shock result of the 2016 presidential election is a warning. Volatility markets « may be have become a little too complacent, « according to Ladislav Jankovic, global currency derivatives strategist at JPMorgan Chase & Co This context, combined with favorable pricing of volatility, » makes it prudent to put in place cheap election hedges, « said he declaredThe word cheap is the key Although there is a possibility that Trump will win, the most likely outcome – at least based on the polls – is that he will lose, and investors may therefore be reluctant to pay a premium. too high to guard against a so-called tail risk With this in mind, Jankovic and colleagues recommend option bets that could benefit from gains in the US dollar A Biden win is seen by many observers to be more negative for the dollar, fueled in part by expectations that it would provide a bigger fiscal stimulus package and that the resulting debt could weigh on the currency It could also help boost investor risk sentiment and undermine the appetite for havens like the dollar A thwarted Trump win, on the other hand, could help prop up the greenback According to JPMorgan, options strategies based on dollar calls – the right to buy greenbacks at a particular price – have generally performed better as a result. of Hillary Clinton’s surprise loss in 2016 than other “risk-free constructions”, such as those involving either euro or yen calls This time around they say using options to bet the dollar will rise against its Australian counterpart looks best, while similar bets on a falling offshore yuan are also worth taking into account This is because the Aussie spot price does not have to move as much as its peers to trigger the option, while the renminbi has been at the center of discussions between China and the US More specifically, they recommend to fund these positions with a dollar / rupee options structure in order to create a « near zero » cost to trade The rupee is not expected to react as much around the election Options strategy has a duration two months to capture risk during and after election MARKET OVERVIEW: On Wednesday, S&P 500 futures swung between losses and gains, while T-bills fell alongside the dollar as speculative lawmakers swung progress on stimulus package funded by trillion dollars in debtBiden Micro Targets Hispanic Voters With New Ads: Campaign Update Pelosi and Mnuchin Take Another Race to Stimulus McConnell Opposes Yields hit their highest level since June as election betting takes over firm accelerate planned sales amid tax hike fears Biden rocked by Trump, auto lobby observes impact of Biden’s presidency Court preparation alternatives begin to gain traction with Democrats $ 114 million ‘advance on Trump campaign Trump burned almost half of his cash in September Trump’ has no connection to China, ‘campaign says on NYT Bank StoryTrump says he could post controversial 60-minute interview with Trump Nemesis Mary Nichols on Biden’s shortlist to run EPA « Wall Street Votes » is a column highlighting the opportunities for the Investors inundated with new policies Click the button at the top to subscribe (Updates to add « Further Reading » section) For more articles like this please visit us at bloomberg Subscribe now to stay up-to-date head with the most trusted source of business news © 2020 Bloomberg LP

AT&T Inc shares fell again in Wednesday’s session after rival Verizon Communications Inc reported morning income, marking AT&T’s longest streak of losses in more than 18 years

Despite an extremely volatile, difficult and unpredictable year 2020, the S&P 500 managed to gain ground to reach new all-time highs in 2020 Investors who bought the bearish on the sale at the start of the year have been rewarded By a rapid market rally Buying from the downside was also a big decision during the Great Recession of 2008, when the S&P 500 lost about 50% of its value, eventually hitting a low of 66679 on March 9, 2009 From the low, SPDR S&P 500 ETF Trust (NYSE: SPY) has generated a total return of 553% over the past 11+ years Wells Fargo Tough Decade: Wells Fargo Big Bank & Co (NYSE: WFC) is one of the markets lagging behind in the past decade Like other US banks, Wells Fargo was hit hard during the financial crisis, but the back stepped in to help stabilize the financial system by buying the securities. Wachovia’s yews for $ 14.8 billion in 2008 Unfortunately for Wells Fargo investors, the company has been plagued by a series of scandals, including a 2016 scandal involving employees creating fraudulent accounts on behalf of clientsWells Fargo shares fell as low as $ 5.67 during the financial crisis, but had returned above $ 27 by early 2010 The 2011 Eurozone debt crisis brought the stock below 23 $, but the back was back, hitting new highs above $ 40 in mid-2013 The rally continued largely halted until the big bank hit $ 58 76 in mid-2015 four years of trading in a range of around $ 45 to $ 60, Wells Fargo shares rose higher in the first few weeks of 2018, hitting their decade high of $ 66The stock has since stagnated thanks in large part to a Federal Reserve cap on the bank’s assets amid the regulatory fallout of the accounts scandal Related link: Here’s how many, 000 investments in JPMorgan during the Great Recession, that Wells Fargo in 2020, Beyond: Wells Fargo fell as low as $ 22 on the 2020 COVID-19 sale and hasn’t gained much ground since Despite the difficult decade, the courageous investors who bought at the bottom of the financial crisis were rewarded In fact, a $ 1,000 worth of Wells Fargo shares bought on the day the S&P 500 hit its low in 2009 would be worth around $ 3,096 today, assuming that dividends reinvestedLooking ahead, analysts expect Wells Fargo to rise further over the next 12 months. The average price target among the 23 analysts covering the stock is $ 27, suggesting a 181% rise by compared to current levels Photo via Wikimedia See more from Benzinga * Option trades for this crazy market: Get options from Benzinga to follow high conviction business ideas * Today in market history: FDIC seizes Wachovia (C) 2020 Benzingacom Benzinga does not provide investment advice All rights reserved

Tesla Inc reports third quarter results above Wall Street expectations on Wednesday, sending the stock higher in the extended session

President Donald Trump says the American dream is at stake this election, while Democratic challenger Joe Biden says his campaign is locked in a « battle for the soul of this nation » How could the candidates influence on things you can see and hold, like a pay stub, tax return, or portfolio statement? Focus on finances puts tax policy at the forefront

Is anyone else fed up with Pelosi’s random daily comments that talks are going well or is hoping and expecting a deal to be done before the election? This is the process in general, as it didn’t take long for Pelosi to admit that while the talks are going well and she wants a pre-election deal, it likely won’t happen. Initially the market climbed after Pelosi’s comments, but we delivered those gains in under 20 minutes

Mexican fast-casual chain Chipotle Mexican Grill reported third quarter profit after close that exceeded expectations, but margins fell Chipotle stock fell

The electric car maker has also affirmed its goal of delivering half a million vehicles by the end of this year, a target that will require it to dramatically increase vehicle sales in the fourth quarter Tesla said it has the installed capacity to produce and deliver 500,000 vehicles this year, but added that meeting its target has become more difficult Earlier this month, Tesla said it delivered 139,300 vehicles in the third quarter, a quarterly record for the electric car maker, but some analysts have questioned whether the company can meet its ambitious year-end goal.

Earlier this month, the Wall Street Journal reported that rival Advanced Micro Devices Inc was in talks to buy Xilinx in a deal that could be valued at over $ 30 billion Xilinx, Based in San Jose, Calif., Manufactures Programmable Chips Used in Data Centers to Accelerate Tasks Like Artificial Intelligence and 5G Telecommunications Base Stations Xilinx Has Seen 38% Sequential Business Growth automotive, echoing a similar impetus underlined by its counterpart Texas Instruments, which credits it with taking over the activities of vehicle assembly plants in North America and Europe

Graphics Chip and Artificial Intelligence Leader Nvidia featured in today’s IBD 50 Stocks To Watch has implemented a new point of purchase

Wealthy Americans living in New York, New Jersey and California could face one of the highest tax rates in decades if Democratic presidential candidate Joe Biden wins the November election

GM appeared to reaffirm its partnership agreement with electric truck maker Nikola as talks to finalize terms dragged on

NASDAQ: ALGN, Alignment Technology, Stock, Clear Aligners

EbeneMagazine – United States – Align’s ClinCheck Suite (ALGN) now commercially available

SOURCE: https://www.w24news.com/news/ebenemagazine-united-states-aligns-clincheck-suite-algn-now-commercially-available/?remotepost=448423


Abonnez-vous à notre chaîne Youtube en cliquant ici

Vidéo du jour: De la cocaïne retrouvée dans une école maternelle de Seine Saint Denis, deux enfants hospitalisés

Laisser un commentaire, votre avis compte!